Trade RDHL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Redhill Biopharma Ltd. American Depositary Shares (RDHL) is trading at US$0.65, up 3.65% today as of Aug 28, 13:00 EDT. The company has a market capitalisation of US$3.83M. Over the past 52 weeks, RDHL has traded between US$0.57 and US$2.79. On Syfe you can trade RDHL with $0 commission and add it to your watchlist.
| Previous close | US$0.63 |
|---|---|
| Market cap | US$3.83M |
| 52-week range | US$0.57 – US$2.79 |
| Volume | 30.22K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Redhill Biopharma Ltd. American Depositary Shares
RedHill Biopharma Ltd. engages in the development and commercialization of drugs for gastrointestinal (GI), infectious diseases, and oncology. The firm's products include Talicia, Movantik, and Aemcolo. It operates through the Commercial Operations and Research and Development segments. The Commercial Operations segment covers areas relating to commercial sales through a subsidiary in the United States. The Research and Development segment includes the study and licensing of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
Year: 2013
RedHill Biopharma Closes Private Placement
Jun 22, 8:42 PM · MT Newswires
RedHill Biopharma's Opaganib Gains FDA Rare Pediatric Disease Status for Neuroblastoma
Jun 9, 11:45 AM · MT Newswires
Stay on top of RDHL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
